A tale of harm, waste and deception: how big pharma has undermined public faith in trial data disclosure and what we can do about it

The article addresses the issue of data stemming from interventional studies in humans conducted by the pharmaceutical industry and how lack of data, or data distortion, can impact on clinical decision making and systematic reviews. The cases of rosiglitazone (Avandia ™, GlaxoSmithKline), rofecoxib...

Full description

Bibliographic Details
Main Author: Vivienne C. Bachelet
Format: Article
Language:English
Published: Medwave Estudios Limitada 2013-05-01
Series:Medwave
Subjects:
Online Access:http://www.mednet.cl/link.cgi/Medwave/Revisiones/Analisis/5671